Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2022 / Articles / Jul / Biologic CDMO Update
Manufacture Contract Manufacturing Services Business Practice Technology & Manufacturing Outsourcing Business & Trends

Biologic CDMO Update

07/26/2022 1 min read

Share

In this first episode of the series, our interviewees are looking to the CDMO facility of Merck in Martillac, where the company is planning an expansion into biologics commercial-scale manufacturing.

Sébastien Ribault is Vice President & Head of Biologics and Viral Vectors CDMO at Merck.

Laetitia Botrel is Head of Large Scale Operations at Merck.


If you have thoughts on anything you heard in this episode and want to share them or contribute to the magazine, then drop me an email at angus.stewart@texerepublishing.com

The life science business of Merck operates as MilliporeSigma in the U.S. and Canada

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

Building a Resilient CGT Workforce
Advanced Medicine Contract Manufacturing Services Business Practice
Building a Resilient CGT Workforce

March 26, 2025

3 min read

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to ensure they are investing in training and mentorship.

The Secret to Being a Good Employer
Contract Manufacturing Services Business Practice Profession
The Secret to Being a Good Employer

February 13, 2025

4 min read

Why you shouldn’t neglect the importance of blending people, culture, and strategy to foster success in a business.

AI Approach to Transdermal GLP-1s
Advanced Medicine Bioprocessing - Single Use Systems Bioprocessing - Upstream & Downstream Dosage Forms Contract Manufacturing Services Biosimilars Packaging Process Control Supply Chain Quality & Compliance
AI Approach to Transdermal GLP-1s

February 25, 2025

3 min read

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

Trends and Technologies in Oral Solid Dosage Formulation
Contract Manufacturing Services Small Molecules
Trends and Technologies in Oral Solid Dosage Formulation

January 16, 2025

3 min read

The trends and challenges in oral solid dosage formulations contribute to greater stability for drugs used by patients worldwide.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.